KBC Group NV Has $203,000 Stake in Exponent, Inc. (NASDAQ:EXPO)

KBC Group NV increased its stake in Exponent, Inc. (NASDAQ:EXPOFree Report) by 62.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,274 shares of the business services provider’s stock after purchasing an additional 874 shares during the quarter. KBC Group NV’s holdings in Exponent were worth $203,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. JPMorgan Chase & Co. raised its holdings in shares of Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the period. International Assets Investment Management LLC acquired a new position in Exponent during the 3rd quarter worth approximately $11,261,000. Geode Capital Management LLC boosted its holdings in Exponent by 4.8% in the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock worth $173,597,000 after acquiring an additional 69,099 shares in the last quarter. Barclays PLC grew its stake in Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after acquiring an additional 66,263 shares during the period. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Exponent by 21.1% during the third quarter. TimesSquare Capital Management LLC now owns 280,090 shares of the business services provider’s stock valued at $32,289,000 after acquiring an additional 48,859 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent Stock Up 0.5 %

Shares of NASDAQ:EXPO opened at $92.27 on Wednesday. The stock’s 50 day moving average is $92.43 and its 200-day moving average is $100.97. Exponent, Inc. has a twelve month low of $74.30 and a twelve month high of $115.75. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of 44.58 and a beta of 0.71.

Insiders Place Their Bets

In other Exponent news, Director Paul R. Johnston sold 7,000 shares of the business’s stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $98.32, for a total transaction of $688,240.00. Following the completion of the sale, the director now directly owns 59,406 shares of the company’s stock, valued at approximately $5,840,797.92. The trade was a 10.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last 90 days, insiders have sold 15,300 shares of company stock worth $1,538,589. Insiders own 2.10% of the company’s stock.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.